On target with tumor blood vessel markers
- 1 November 1997
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 15 (12) , 1243-1244
- https://doi.org/10.1038/nbt1197-1243
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformNature Biotechnology, 1997
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Addressing tumor blood vesselsNature Biotechnology, 1997
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor VasculatureScience, 1997
- Mechanisms and therapeutic implications of angiogenesisCurrent Opinion in Oncology, 1996
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Making Antibodies by Phage Display TechnologyAnnual Review of Immunology, 1994
- Angiogenesis inhibition: A reviewPharmacology & Therapeutics, 1994
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971